Renal Denervation Market Report: Trends, Forecast and Competitive Analysis
Renal Denervation Market Trends and Forecast
The future of the renal denervation market looks promising with opportunities in the hospitals, clinics, ambulatory surgical centers and other markets. The global renal denervation market is expected to grow with a CAGR of 36% to 38% from 2023 to 2028. The major drivers for this market are rising frequency of hypertension, increasing elderly population and clinical advantages.
Renal Denervation Market by Technology, Product, Disease, and End Use Industry
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched and other details of the global renal denervation market report, please download the report brochure.
Renal Denervation Market by Segments
Renal Denervation Market by Segment
The study includes a forecast for the global renal denervation market by technology, product type, disease type, end use industry, and region, as follows:
Renal Denervation Market by Technology [Value ($B) Shipment Analysis from 2017 to 2028]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies renal denervation companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the renal denervation companies profiled in this report include.
Q1. What is the renal denervation market size?
Answer: The global renal denervation market is expected to reach an estimated $xx billion by 2028.
Q2. What is the growth forecast for renal denervation market?
Answer: The global renal denervation market is expected to grow with a CAGR of 36% to 38% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the renal denervation market?
Answer: The major drivers for this market are rising frequency of hypertension, increasing elderly population and clinical advantages.
Q4. What are the major segments for renal denervation market?
Answer: The future of the renal denervation market looks promising with opportunities in the hospitals, clinics, ambulatory surgical centers and other markets
Q5. Who are the key renal denervation companies?
Answer: Some of the key renal denervation companies are as follows:
Answer: Lucintel forecasts that enligHTN will remain the largest segment over the forecast period due to the rising implementation of clinical studies to examine its efficacy in treating drug-resistant, uncontrolled hypertension.
Q7. In renal denervation market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to the increasing diagnosis and treatment rates, high adoption of advanced devices and growing number of research and development activities.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the renal denervation market by technology (micro infusion, pharmacologic ablation, radiofrequency ablation, and ultrasound ablation), product type (enligHTN RD system, symplicity RD system, vessix RD system, paradise RD system, iberis RD system and others), disease type (hypertension, heart failure, diabetes, renal failure and others), end use industry (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to renal denervation market or related to renal denervation companies, renal denervation market size, renal denervation market share, renal denervation analysis
The future of the renal denervation market looks promising with opportunities in the hospitals, clinics, ambulatory surgical centers and other markets. The global renal denervation market is expected to grow with a CAGR of 36% to 38% from 2023 to 2028. The major drivers for this market are rising frequency of hypertension, increasing elderly population and clinical advantages.
Renal Denervation Market by Technology, Product, Disease, and End Use Industry
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched and other details of the global renal denervation market report, please download the report brochure.
Renal Denervation Market by Segments
Renal Denervation Market by Segment
The study includes a forecast for the global renal denervation market by technology, product type, disease type, end use industry, and region, as follows:
Renal Denervation Market by Technology [Value ($B) Shipment Analysis from 2017 to 2028]:
- Micro infusion
- Pharmacologic ablation
- Radiofrequency ablation
- Ultrasound ablation
- EnligHTN RD system
- Symplicity RD system
- Vessix RD system
- Paradise RD system
- Iberis RD system
- Others
- Hypertension
- Heart failure
- Diabetes
- Renal failure
- Others
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies renal denervation companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the renal denervation companies profiled in this report include.
- Medtronic
- Boston Scientific
- Kona Medical; Abbott
- CardioSonic
- Renal Dynamics
- Ablative Solutions
- Lucintel forecasts that enligHTN will remain the largest segment over the forecast period due to the rising implementation of clinical studies to examine its efficacy in treating drug-resistant, uncontrolled hypertension.
- Ultrasound ablation is expected to remain the largest segment due to its efficacy in trials and high effectiveness of catheter-based renal denervation procedures.
- North America will remain the largest region due to the increasing diagnosis and treatment rates, high adoption of advanced devices and growing number of research and development activities in the region.
- Market Size Estimates: Renal Denervation market size estimation in terms of value ($B)
- Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Renal Denervation market size by various segments, such as by technology, product type, disease type, end use industry, and region
- Regional Analysis: Renal Denervation market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different by technology, product type, disease type, end use industry, and regions for the renal denervation market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the renal denervation market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q1. What is the renal denervation market size?
Answer: The global renal denervation market is expected to reach an estimated $xx billion by 2028.
Q2. What is the growth forecast for renal denervation market?
Answer: The global renal denervation market is expected to grow with a CAGR of 36% to 38% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the renal denervation market?
Answer: The major drivers for this market are rising frequency of hypertension, increasing elderly population and clinical advantages.
Q4. What are the major segments for renal denervation market?
Answer: The future of the renal denervation market looks promising with opportunities in the hospitals, clinics, ambulatory surgical centers and other markets
Q5. Who are the key renal denervation companies?
Answer: Some of the key renal denervation companies are as follows:
- Medtronic
- Boston Scientific
- Kona Medical; Abbott
- CardioSonic
- Renal Dynamics
- Ablative Solutions
Answer: Lucintel forecasts that enligHTN will remain the largest segment over the forecast period due to the rising implementation of clinical studies to examine its efficacy in treating drug-resistant, uncontrolled hypertension.
Q7. In renal denervation market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to the increasing diagnosis and treatment rates, high adoption of advanced devices and growing number of research and development activities.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the renal denervation market by technology (micro infusion, pharmacologic ablation, radiofrequency ablation, and ultrasound ablation), product type (enligHTN RD system, symplicity RD system, vessix RD system, paradise RD system, iberis RD system and others), disease type (hypertension, heart failure, diabetes, renal failure and others), end use industry (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to renal denervation market or related to renal denervation companies, renal denervation market size, renal denervation market share, renal denervation analysis
1. EXECUTIVE SUMMARY
2. GLOBAL RENAL DENERVATION MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Renal Denervation Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Renal Denervation Market by Technology
3.3.1: Micro Infusion
3.3.2: Pharmacologic Ablation
3.3.3: Radiofrequency Ablation
3.3.4: Ultrasound Ablation
3.4: Global Renal Denervation Market by Product Type
3.4.1: EnligHTN RD System
3.4.2: Symplicity RD System
3.4.3: Vessix RD System
3.4.4: Paradise RD System
3.4.5: Iberis RD System
3.4.6: Others
3.5: Global Renal Denervation Market by Disease Type
3.5.1: Hypertension
3.5.2: Heart Failure
3.5.3: Diabetes
3.5.4: Renal Failure
3.5.5: Others
3.6: Global Renal Denervation Market by End Use Industry
3.6.1: Hospitals
3.6.2: Clinics
3.6.3: Ambulatory Surgical Centers
3.6.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017-2028
4.1: Global Renal Denervation Market by Region
4.2: North American Renal Denervation Market
4.2.1: North American Renal Denervation Market by Technology: Micro Infusion, Pharmacologic Ablation, Radiofrequency Ablation, and Ultrasound Ablation
4.2.2: North American Renal Denervation Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers and Others
4.3: European Renal Denervation Market
4.3.1: European Renal Denervation Market by Technology: Micro Infusion, Pharmacologic Ablation, Radiofrequency Ablation, and Ultrasound Ablation
4.3.2: European Renal Denervation Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers and Others
4.4: APAC Renal Denervation Market
4.4.1: APAC Renal Denervation Market by Technology: Micro Infusion, Pharmacologic Ablation, Radiofrequency Ablation, and Ultrasound Ablation
4.4.2: APAC Renal Denervation Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers and Others
4.5: ROW Renal Denervation Market
4.5.1: ROW Renal Denervation Market by Technology: Micro Infusion, Pharmacologic Ablation, Radiofrequency Ablation, and Ultrasound Ablation
4.5.2: ROW Renal Denervation Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Renal Denervation Market by Technology
6.1.2: Growth Opportunities for the Global Renal Denervation Market by Product Type
6.1.3: Growth Opportunities for the Global Renal Denervation Market by Disease Type
6.1.4: Growth Opportunities for the Global Renal Denervation Market by End Use Industry
6.1.5: Growth Opportunities for the Global Renal Denervation Market by Region
6.2: Emerging Trends in the Global Renal Denervation Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Renal Denervation Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Renal Denervation Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Medtronic
7.2: Boston Scientific
7.3: Kona Medical; Abbott
7.4: CardioSonic
7.5: Renal Dynamics
7:6: ABLATIVE SOLUTIONS
2. GLOBAL RENAL DENERVATION MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Renal Denervation Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Renal Denervation Market by Technology
3.3.1: Micro Infusion
3.3.2: Pharmacologic Ablation
3.3.3: Radiofrequency Ablation
3.3.4: Ultrasound Ablation
3.4: Global Renal Denervation Market by Product Type
3.4.1: EnligHTN RD System
3.4.2: Symplicity RD System
3.4.3: Vessix RD System
3.4.4: Paradise RD System
3.4.5: Iberis RD System
3.4.6: Others
3.5: Global Renal Denervation Market by Disease Type
3.5.1: Hypertension
3.5.2: Heart Failure
3.5.3: Diabetes
3.5.4: Renal Failure
3.5.5: Others
3.6: Global Renal Denervation Market by End Use Industry
3.6.1: Hospitals
3.6.2: Clinics
3.6.3: Ambulatory Surgical Centers
3.6.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017-2028
4.1: Global Renal Denervation Market by Region
4.2: North American Renal Denervation Market
4.2.1: North American Renal Denervation Market by Technology: Micro Infusion, Pharmacologic Ablation, Radiofrequency Ablation, and Ultrasound Ablation
4.2.2: North American Renal Denervation Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers and Others
4.3: European Renal Denervation Market
4.3.1: European Renal Denervation Market by Technology: Micro Infusion, Pharmacologic Ablation, Radiofrequency Ablation, and Ultrasound Ablation
4.3.2: European Renal Denervation Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers and Others
4.4: APAC Renal Denervation Market
4.4.1: APAC Renal Denervation Market by Technology: Micro Infusion, Pharmacologic Ablation, Radiofrequency Ablation, and Ultrasound Ablation
4.4.2: APAC Renal Denervation Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers and Others
4.5: ROW Renal Denervation Market
4.5.1: ROW Renal Denervation Market by Technology: Micro Infusion, Pharmacologic Ablation, Radiofrequency Ablation, and Ultrasound Ablation
4.5.2: ROW Renal Denervation Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Renal Denervation Market by Technology
6.1.2: Growth Opportunities for the Global Renal Denervation Market by Product Type
6.1.3: Growth Opportunities for the Global Renal Denervation Market by Disease Type
6.1.4: Growth Opportunities for the Global Renal Denervation Market by End Use Industry
6.1.5: Growth Opportunities for the Global Renal Denervation Market by Region
6.2: Emerging Trends in the Global Renal Denervation Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Renal Denervation Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Renal Denervation Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Medtronic
7.2: Boston Scientific
7.3: Kona Medical; Abbott
7.4: CardioSonic
7.5: Renal Dynamics
7:6: ABLATIVE SOLUTIONS
